Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00009035 · ClinicalTrials.gov registry record
Natural History of Patients With Brain and Spinal Cord Tumors
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 3,050
- Enrollment target
NCT00009035: Completed study, sponsored by National Cancer Institute (NCI).
NCT00009035 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 3,050 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00009035 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 3,050 participants
- Enrollment target
Study Summary
This study offers evaluation of patients with brain and spinal cord tumors. Its purpose is threefold: 1) to allow physicians in NIH s Neuro-Oncology Branch to increase their knowledge of the course of central nervous system tumors and identify areas that need further research; 2) to inform participants of new studies at the National Cancer Institute and other centers as they are developed; and 3) to provide patients consultation on possible treatment options. Children (at least 1 year old) and adults with primary malignant brain and spinal cord tumors may be eligible for this study. Participants will have a medical history, physical and neurological examinations and routine blood tests. They may also undergo one or more of the following procedures: * Magnetic resonance imaging (MRI) MRI is a diagnostic tool that uses a strong magnetic field and radio waves instead of X-rays to show detailed changes in brain structure and chemistry. For the procedure, the patient lies on a table in a narrow cylinder containing a magnetic field. A contrast material called gadolinium may be used (injected into a vein) to enhance the images. The procedure takes about an hour, and the patient can speak with a staff member via an intercom system at all times. * Computed axial tomography (CAT or CT) CT is a specialized form of X-ray imaging that produces 3-dimensional images of the brain in sections. The scanner is a ring device that surrounds the patient and contains a moveable X-ray source. The scan takes about 30 minutes and may be done with or without the use of a contrast dye. * Positron emission tomography (PET) PET is a diagnostic test that is based on differences in how cells take up and use glucose (sugar), one of the body s main fuels. The patient is given an injection of radioactive glucose. A special camera surrounding the patient detects the radiation emitted by the radioactive material and produces images that show how much glucose is being used by various tissues. Fast-gro
Primary Outcome
Generalized knowledge about CNS Tumors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,050 participants |
| Start Date | 2001-01-22 |
| Est. Completion | 2018-09-11 |
What the finished NCT00009035 record still lists
NCT00009035 is an observational study that tracks outcomes without assigning an intervention. Its 3,050 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00009035 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00009035 about?
NCT00009035 is a clinical study titled "Natural History of Patients With Brain and Spinal Cord Tumors". This study offers evaluation of patients with brain and spinal cord tumors. Its purpose is threefold: 1) to allow physicians in NIH s Neuro-Oncology Branch to increase their knowledge of the course of central nervous system tumors and identify areas that need further research; 2) to inform participa...
What is the current status of trial NCT00009035?
This trial is currently completed. The enrollment target is 3,050 participants. The study started on 2001-01-22. Estimated completion is 2018-09-11.
Who is sponsoring clinical trial NCT00009035?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT06667700 · 3,082 participants · Phase 3
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- NCT05534243 · 3,090 participants · NA
The ED-AWARENESS-2 Trial
- NCT04722822 · 3,100 participants · NA
The HPV 9-10 Trial: Early Initiation of HPV Vaccination
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI